|
CCDC43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.05153688376458E-12 |
| Normal-vs-Stage2 |
2.816500E-03 |
| Normal-vs-Stage3 |
3.212200E-04 |
| Normal-vs-Stage4 |
1.565820E-02 |
| Stage1-vs-Stage2 |
9.877800E-01 |
| Stage1-vs-Stage3 |
6.091000E-01 |
| Stage1-vs-Stage4 |
2.284400E-01 |
| Stage2-vs-Stage3 |
7.354600E-01 |
| Stage2-vs-Stage4 |
3.546000E-01 |
| Stage3-vs-Stage4 |
4.952200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
2.20560000041559E-07 |
| Normal-vs-Asian |
1.008360E-01 |
| Caucasian-vs-AfricanAmerican |
3.951000E-01 |
| Caucasian-vs-Asian |
3.717000E-01 |
| AfricanAmerican-vs-Asian |
2.046800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53210777398272E-14 |
| Normal-vs-Female |
8.33140223477358E-11 |
| Male-vs-Female |
8.127900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.98000000000743E-05 |
| Normal-vs-Extreme_Weight |
1.543499994483E-08 |
| Normal-vs-Obese |
1.46120000543704E-08 |
| Normal-vs-Extreme_Obese |
4.875700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.485400E-01 |
| Normal_Weight-vs-Obese |
8.725800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.088200E-01 |
| Extreme_Weight-vs-Obese |
9.106800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.161600E-01 |
| Obese-vs-Extreme_Obese |
8.451200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.806200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(61-80Yrs) |
2.24370000356799E-09 |
| Normal-vs-Age(81-100Yrs) |
5.247900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.524570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.510200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.663660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.202800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.718000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.569200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
2.13019999999453E-05 |
| Normal-VS-KIRP CIMP |
5.416300E-03 |
| Normal-VS-Unclassified PRCC |
4.426700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.861900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.874100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.439800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.521700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.240600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.967580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.183990E-04 |
| Normal-vs-N1 |
2.770900E-04 |
| Normal-vs-N2 |
1.938990E-01 |
| N0-vs-N1 |
3.818000E-02 |
| N0-vs-N2 |
2.600600E-01 |
| N1-vs-N2 |
9.852800E-01 |
|
|
